Stijn Koolen

Dr. Stijn Koolen is an Associate Professor at Erasmus MC, Erasmus University Rotterdam, affiliated with the departments of Medical Oncology, Radiology & Nuclear Medicine, and Pharmacy. His research focuses on pharmacology, oncology, and drug development, with particular emphasis on pharmacokinetics, therapeutic drug monitoring, and clinical oncology. He has contributed to over 141 research outputs and actively collaborates across multiple institutions.

Research interests include drug interactions, personalized cancer therapies, and optimizing drug regimens for improved patient outcomes. Recent studies involve pharmacokinetic analyses of olaparib, semaglutide-alectinib interactions, breast cancer treatment efficacy, gastric cancer metastasis prognostics, and cost-effective dosing of enfortumab vedotin.

Dr. Koolen has supervised 8 academic works and maintains an ORCID identifier (0000-0973-7530). His work bridges clinical research and practical applications in oncology and pharmacology.